|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/20 | (2006.01) | ||
| A61K 31/4535 | (2006.01) |
| (11) | Number of the document | 3072504 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16163199.9 |
| Date of filing the European patent application | 2007-01-08 | |
| (97) | Date of publication of the European application | 2016-09-28 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 756937 P | 2006-01-06 | US | |
| 650174 | 2007-01-05 | US |
| (72) |
PALMER, Pamela, US
SCHRECK, Thomas, US
TZANNIS, Stelios, US
HAMEL, Larry, US
POUTIATINE, Andrew, US
|
| (73) |
AcelRx Pharmaceuticals, Inc.,
351 Galveston Dr, Redwood City, CA 94063,
US
|
| (54) | SMALL-VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS |
| SMALL-VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS |